Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for TELA Bio, Inc. (TELA : NSDQ)

• Company Description    TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered in Malvern, Pennsylvania. Number of Employees: 150

• Price / Volume Information    Yesterday's Closing Price: $1.08 Daily Weekly Monthly 20 Day Moving Average: 156,555 shares Shares Outstanding: 45.14 (millions) Market Capitalization: $48.76 (millions) Beta: 1.36 52 Week High: $1.52 52 Week Low: $0.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -16.92% -17.47% 12 Week 59.41% 50.35% Year To Date -8.47% -19.23%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 GREAT VALLEY PARKWAY SUITE 24 - MALVERN,PA 19355 USA ph: 484-320-2930 fax: - ir@telabio.com http://www.telabio.com

• General Corporate Information    Officers Antony Koblish - Chief Executive Officer and Director Doug Evans - Chairman; Board of Directors Roberto Cuca - Chief Operating Officer and Chief Financial Office Megan Smeykal - Chief Accounting Officer and Controller Kurt Azarbarzin - Director Peer Information TELA Bio, Inc. (CORR.) TELA Bio, Inc. (RSPI) TELA Bio, Inc. (CGXP) TELA Bio, Inc. (BGEN) TELA Bio, Inc. (GTBP) TELA Bio, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 872381108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 45.14 Most Recent Split Date: (:1) Beta: 1.36 Market Capitalization: $48.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.76 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.61 EPS Growth vs. Year Ago Period: 9.09% vs. Previous Quarter: 4.76% Sales Growth vs. Year Ago Period: -4.49% vs. Previous Quarter: 1.22% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - -1,320.81 ROA 09/30/26 - - 06/30/26 - -59.39 03/31/26 - -55.83 Current Ratio 09/30/26 - - 06/30/26 - 2.99 03/31/26 - 3.61 Quick Ratio 09/30/26 - - 06/30/26 - 2.38 03/31/26 - 2.92 Operating Margin 09/30/26 - - 06/30/26 - -50.66 03/31/26 - -48.43 Net Margin 09/30/26 - - 06/30/26 - -51.53 03/31/26 - -49.30 Pre-Tax Margin 09/30/26 - - 06/30/26 - -51.20 03/31/26 - -49.00 Book Value 09/30/26 - - 06/30/26 - -0.35 03/31/26 - -0.12 Inventory Turnover 09/30/26 - - 06/30/26 - 2.21 03/31/26 - 2.26 Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©